WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'2701 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 5'0841 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 8'075  7'962  7'849  7'736  7'621  6'243  4'903  3'636 
Births 169  169  170  171  172  197  188  158 
Surviving infants 164  165  165  166  167  190  179  147 
Pop. less than 5 years 816  823  835  849  861  951  845  672 
Pop. less than 15 years 2'565  2'590  2'618  2'646  2'671  2'651  2'229  1'707 
Female 15-49 years 2'212  2'165  2'115  2'064  2'012  1'492  1'104  785 

Number of reported cases

(Click for retrospective incidence data for Honduras)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  8'360  4'188 
Mumps
ChartChart
  108  136  158  138  143  853 
Pertussis
ChartChart
  30  41  25  48  113  169  65  2'503 
Polio*
ChartChart
 
Rubella
ChartChart
  201 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  39 
Tetanus (total)**
ChartChart
  17  12  17  14  62  31 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Honduras)
Vaccine year result method % card seen                                                
BCG 2011  99  DHS   90  99*  86  87  89  99*  99  70  25 
DTP1 2011  99  DHS   90  99*  86  88  88  99*  98 
DTP3 2011  95  DHS   90  99  85  87  88  99*  94  84  28 
DTP4          97  89 
IPV1          99* 
HepB_BD          83  99*  99*  98  98 
HepB3 2011  95  DHS   90  99  85  87  88  99*  94 
Hib3 2011  95  DHS   90  99  85  87  88  99*  94 
JapEnc         
MCV1          98  88  89  93  99*  98  90  31 
MCV2         
PCV1          99*  86  87  88  99* 
PCV3          99  85  87  88  78 
Pol3 2011  96  DHS   90  99  85  87  88  99*  88  87  31 
Rota1          99*  85  87  87  99* 
RotaC          99*  85  87  87  99* 
RCV1          98  88  89  93  99* 
TT2plus 2000  16  FHS   87  99*  99*  99*  99*  99*  99*  49 
PAB         
VAD1          90  58  83  94  81  84 
YFV          99*  99*  99*  99*  99* 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Honduras)
BCG
ChartChart
  88  86  87  89  93  99  70  25 
DTP1
ChartChart
  88  86  88  88  92  98  94  53 
DTP3
ChartChart
  85  85  87  88  91  94  84  28 
HepB3
ChartChart
  85  85  87  88  91  94 
HepB_BD
ChartChart
  72  69  62  63  77 
Hib3
ChartChart
  85  85  87  88  91  94 
IPV1
ChartChart
 
MCV1
ChartChart
  87  88  89  93  95  98  90  31 
MCV2
ChartChart
 
PAB
ChartChart
  94  94  94  94  94  93  60 
PCV3
ChartChart
  85  85  87  88  78 
Pol3
ChartChart
  85  85  87  88  91  88  87  31 
RCV1
ChartChart
  87  88  89  93  95  98 
RotaC
ChartChart
  86  85  87  87  93 

Number of districts in the country 298  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 69
From 80 to 89% 16
From 50 to 79% 14
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 4, 6, 18 months; 4 years; Yes risk groups
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV Yes From May 2016
HepB_Adult 1st contact; +1, +6 months; Yes risk group
HepB_Pediatric birth; Yes
IPV 2 months; Yes and 1st contact; +4, +6 months for risk groups
Influenza_Adult >= 60 years; Yes and adults with chronic diseases, health care workers, pregnant women and other risk groups
Influenza_Pediatric Yes Children with chronical diseases
MMR 12 months; Yes
MR No risk groups
OPV 2, 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus 2, 4 months; Yes
Td 11, 21 years; Yes every 10 years & pregnant women not yet vaccinated with 5 doses
VitaminA 6-11 months; Yes every 6 months
YF > 1 year; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2011-2015  2011-2015  2011-2015  2011-2015  2010-2015  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 78  78  87  112  110  110  104 

System performance

Total Nº districts in country number 298  298  298  298  298  298  298 
Nº districts with DTP3 coverage >=80% number 254  170  189  230  289  281  285 
% of districts with DTP3 coverage >=80% From 0 to 100% 85  57  63  77  97  94  96 
Nº districts with measles (MCV1) coverage >=95% number 177  100  100  165  250  212  199 
% of districts with MCV1 coverage >=95% From 0 to 100% 59  34  34  55  84  71  67 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 77  79  67  60  49  66  75 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.